Paper · 12379721
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 35
Download this page as JSON| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9,841,833 | Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. | J Infect Dis | 1999 | https://conductscience.org/library/papers/9841833 | PubMed |
| 2 | 9,784,550 | Impact of M49, Mrp, Enn, and C5a peptidase proteins on colonization of the mouse oral mucosa by Streptococcus pyogenes. | Infect Immun | 1998 | https://conductscience.org/library/papers/9784550 | PubMed |
| 3 | 10,189,305 | 1997 AAP guidelines for prevention of early-onset group B streptococcal disease. | Pediatrics | 1999 | https://conductscience.org/library/papers/10189305 | PubMed |
| 4 | 10,225,912 | Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines. | Infect Immun | 1999 | https://conductscience.org/library/papers/10225912 | PubMed |
| 5 | 14,461,914 | Current knowledge of type-specific M antigens of group A streptococci. | J Immunol | 1962 | https://conductscience.org/library/papers/14461914 | PubMed |
| 6 | 10,713,053 | Characterization of the linkage between the type III capsular polysaccharide and the bacterial cell wall of group B Streptococcus. | J Biol Chem | 2000 | https://conductscience.org/library/papers/10713053 | PubMed |
| 7 | 10,809,707 | Characterization of the streptococcal C5a peptidase using a C5a-green fluorescent protein fusion protein substrate. | J Bacteriol | 2000 | https://conductscience.org/library/papers/10809707 | PubMed |
| 8 | 10,948,119 | Genetic polymorphisms of group B streptococcus scpB alter functional activity of a cell-associated peptidase that inactivates C5a. | Infect Immun | 2000 | https://conductscience.org/library/papers/10948119 | PubMed |
| 9 | 11,115,709 | Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization. | Vaccine | 2000 | https://conductscience.org/library/papers/11115709 | PubMed |
| 10 | 11,254,587 | Antibody against surface-bound C5a peptidase is opsonic and initiates macrophage killing of group B streptococci. | Infect Immun | 2001 | https://conductscience.org/library/papers/11254587 | PubMed |
| 11 | 11,953,377 | The group B streptococcal C5a peptidase is both a specific protease and an invasin. | Infect Immun | 2002 | https://conductscience.org/library/papers/11953377 | PubMed |
| 12 | 12,010,974 | Identification of novel adhesins from Group B streptococci by use of phage display reveals that C5a peptidase mediates fibronectin binding. | Infect Immun | 2002 | https://conductscience.org/library/papers/12010974 | PubMed |
| 13 | 1,105,186 | A comparison of early-onset group B streptococcal neonatal infection and the respiratory-distress syndrome of the newborn. | N Engl J Med | 1976 | https://conductscience.org/library/papers/1105186 | PubMed |
| 14 | 768,760 | Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. | N Engl J Med | 1976 | https://conductscience.org/library/papers/768760 | PubMed |
| 15 | 57,196 | Pulmonary changes in neonatal sepsis to group B beta-hemolytic Streptococcus: relation of hyaline membrane disease. | J Infect Dis | 1976 | https://conductscience.org/library/papers/57196 | PubMed |
| 16 | 344,223 | Adult mice as a model for early onset group B streptococcal disease. | Infect Immun | 1978 | https://conductscience.org/library/papers/344223 | PubMed |
| 17 | 3,898,306 | Group B streptococcal vaccines. | Rev Infect Dis | 1985 | https://conductscience.org/library/papers/3898306 | PubMed |
| 18 | 3,053,900 | Group B streptococci inhibit the chemotactic activity of the fifth component of complement. | J Immunol | 1988 | https://conductscience.org/library/papers/3053900 | PubMed |
| 19 | 2,243,123 | Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. | J Clin Invest | 1990 | https://conductscience.org/library/papers/2243123 | PubMed |
| 20 | 1,996,961 | Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus. | Biochem J | 1991 | https://conductscience.org/library/papers/1996961 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/12379721/references